Clinical Trial

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Study acronym: AIRFLOW-3
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2018-08-17; most recent amendment 2024-11-12.
Status change: Recruiting → Active, Not Recruiting 2023-09-07
Status change: Not Yet Recruiting → Recruiting 2019-06-25
Trial Details
NCT Number NCT03639051
Lead Sponsor Nuvaira, Inc.
Conditions COPD
Enrollment 464 participants
Start Date 2019-05-23
Primary Completion 2024-10-01 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2024-11-14